SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Abbott Laboratories Announces Three-Year Long-Term Data Evaluating Efficacy with HUMIRA® (Adalimumab) for Patients With Moderately to Severely Active Ulcerative Colitis